Back to News
investment

5 Dividend Aristocrats Where Analysts See Capital Gains

BNK Invest
Loading...
4 min read
0 likes
⚡ Quantum Brief
Five Dividend Aristocrats—companies with 20+ years of consecutive dividend increases—show significant upside potential, per analyst targets, combining dividend growth with capital gains. Abbott Laboratories (ABT) leads with 8.24% upside to its $140.33 target, followed by Sherwin-Williams (SHW) at 7.77%, outpacing peers in the S&P High Yield Dividend Aristocrats Index. Total return potential, including dividends, ranges from 6.93% (RenaissanceRe) to 10.13% (AbbVie), with AbbVie’s 4.22% yield and 5.91% price upside driving the highest projected gains. Dividend growth varies sharply: Abbott’s payout surged 57.64% year-over-year, while McDonald’s grew just 4.17%, highlighting divergent strategies among Aristocrats. Analyst data from Zacks via Quandl underscores these stocks’ dual appeal—reliable income plus price appreciation—amid broader market demand for dividend consistency.
AI Audio Summary
0:00 / 0:00
Click to play
Untitled design (19).png
Quantum News · Media Library

AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA Markets ABT 5 Dividend Aristocrats Where Analysts See Capital Gains January 14, 2022 — 10:37 am EST Written by BNK Invest for BNK Invest-> To become a "Dividend Aristocrat," a dividend paying company must accomplish an incredible feat: consistently increase shareholder dividends every year for at least 20 consecutive years. Companies with this kind of track record tend to attract a lot of investor attention — and furthermore, "tracking" funds that follow the Dividend Aristocrats Index must own them. With all of this demand for shares, dividend growth stocks can sometimes become "fully priced," where there isn't much upside to analyst targets. But we here at ETF Channel have looked through the underlying holdings of the SPDR S&P Dividend ETF (which tracks the S&P High Yield Dividend Aristocrats Index), and found these five dividend growth stocks that actually still have fairly substantial upside to the average analyst target price 12 months out. Which means, if the analysts are correct, these are five dividend growth stocks that could produce capital gains in addition to their growing dividend payments. In the first table below, we present the five stocks. The recent share price, average analyst 12-month target price, and percentage upside to reach the analyst target are presented.

Stock Recent Price Avg. Analyst 12-Mo. Target % Upside to TargetAbbott Laboratories (Symbol: ABT) $129.65 $140.33 8.24%Sherwin-Williams Co (Symbol: SHW) $317.39 $342.06 7.77%RenaissanceRe Holdings Ltd. (Symbol: RNR) $169.68 $180.00 6.08%AbbVie Inc (Symbol: ABBV) $133.52 $141.42 5.91%McDonald's Corp (Symbol: MCD) $261.41 $275.29 5.31%The average 12-month analyst targets are only targets for the share price however, and each of these stocks are expected to pay dividends during that holding period — so the expected total return if these stocks reach their analyst targets is actually the share price upside seen by the analysts plus the dividend yield shareholders can expect. To ballpark that total return potential, we have added the current yield to the analyst target price upside, in order to arrive at the 12-month total return potential: Stock Dividend Yield % Upside to Analyst Target Implied Total Return Potential Abbott Laboratories (Symbol: ABT) 1.45% 8.24% 9.69%Sherwin-Williams Co (Symbol: SHW) 0.69% 7.77% 8.46%RenaissanceRe Holdings Ltd. (Symbol: RNR) 0.85% 6.08% 6.93%AbbVie Inc (Symbol: ABBV) 4.22% 5.91% 10.13%McDonald's Corp (Symbol: MCD) 2.11% 5.31% 7.42%Another consideration with dividend growth stocks is just how much the dividend is growing. We looked up the trailing twelve months worth of dividends shareholders of each of the above five companies have collected, and then also looked up the same number for the prior trailing twelve months. This gives us a rough yardstick to see how much the dividend has grown, from one trailing twelve month period to another. Stock Prior TTM Dividend TTM Dividend % GrowthAbbott Laboratories (Symbol: ABT) $1.44 $2.27 57.64%Sherwin-Williams Co (Symbol: SHW) $1.78666666666667 $2.2 23.13%RenaissanceRe Holdings Ltd. (Symbol: RNR) $1.4 $1.44 2.86%AbbVie Inc (Symbol: ABBV) $4.72 $6.61 40.04%McDonald's Corp (Symbol: MCD) $5.04 $5.25 4.17%These five stocks are part of our full Dividend Aristocrats List. The average analyst target price data upon which this article was based, is courtesy of data provided by Zacks Investment Research via Quandl.com.Get the latest Zacks research report on ABBV — FREEGet the latest Zacks research report on MCD — FREE Dividend Growth Stocks: 25 Aristocrats » The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Tags MarketsStocksETFs BNK Invest BNK Invest Inc. provides investment services and information. BNK Invest owns and operates a market news family of websites including DividendChannel, ETFChannel, StockOptionsChannel, and others, which make up an investor community featuring stock message boards, ratings, research, and strategies. BNK Invest caters to investing firms and individual investors internationally.

Cheap Materials Shares-> MILE Earnings History-> BOAC market cap history-> More articles by this source-> Stocks mentioned ABT SHW RNR ABBV MCD More Related Articles This data feed is not available at this time. Data is currently not available • Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.

Read Original

Source Information

Discussion

0 professional contributions

Sign in to join this professional discussion.

Be the first to add a constructive contribution.